Kinnate Biopharma Inc. (NasdaqGS:KNTE) acquired Kinnjiu Biopharma Limited from Series A Investors of the China Joint Venture for $24 million on February 21, 2023. The transaction was approved by the independent directors of Kinnate.

Kinnate Biopharma Inc. (NasdaqGS:KNTE) completed the acquisition of Kinnjiu Biopharma Limited from Series A Investors of the China Joint Venture for $24 million on February 21, 2023.